Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More General news updates Indian 2 rollercoaster: Kamal Haasan’s latest hits Rs 70cr amidst critic battles Kamal Haasan, a luminary of Indian cinema, continues his success streak into 2024 with notable roles that have… byPallavi MadhirajuJuly 20, 2024